{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:14Z","timestamp":1787003714626,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00101-7","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T09:01:21Z","timestamp":1746176481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Double reflex testing improves the efficacy and cost effectiveness of hepatitis delta diagnosis in southern Spain"],"prefix":"10.1038","volume":"15","author":[{"given":"Ana","family":"Fuentes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"Est\u00e9vez-Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"De Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Ruiz","family":"Escolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Montiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Alados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Crist\u00f3bal","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Bel\u00e9n","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar Barrera","family":"Baena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anny","family":"Camelo-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Palop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo Gonz\u00e1lez","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Viciana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M Pinazo","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Fern\u00e1ndez","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Carmen","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Gir\u00e1ldez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Carmen","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota Jimeno","family":"Mat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Encarnaci\u00f3n Ram\u00edrez","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Franco \u00c1lvarez","family":"De Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"del Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto De la Iglesia","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Sampedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa \u00c1ngeles L\u00f3pez","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Pilar","family":"Luz\u00f3n-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Salas-Coronas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Freyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n Santamar\u00eda","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Rosales-Zabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Dom\u00ednguez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"101_CR1","doi-asserted-by":"publisher","first-page":"104812","DOI":"10.1016\/j.antiviral.2020.104812","volume":"179","author":"J Lucifora","year":"2020","unstructured":"Lucifora, J. & Delphin, M. Current knowledge on Hepatitis Delta Virus replication. Antiviral Res. 179, 104812 (2020).","journal-title":"Antiviral Res."},{"key":"101_CR2","unstructured":"Organizaci\u00f3n Mundial de la Salud (OMS). Hepatitis D. Ginebra: OMS. https:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/hepatitis-d, (2023)."},{"issue":"3","key":"101_CR3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.dld.2018.09.008","volume":"51","author":"G Brancaccio","year":"2019","unstructured":"Brancaccio, G. et al. The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort. Dig. Liver Dis. 51(3), 438\u2013442 (2019).","journal-title":"Dig. Liver Dis."},{"issue":"5","key":"101_CR4","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1053\/j.gastro.2009.01.052","volume":"136","author":"R Romeo","year":"2009","unstructured":"Romeo, R. et al. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 136(5), 1629\u20131638 (2009).","journal-title":"Gastroenterology"},{"issue":"5","key":"101_CR5","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jhep.2020.06.038","volume":"73","author":"D Roulot","year":"2020","unstructured":"Roulot, D. et al. Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta. J. Hepatol. 73(5), 1046\u20131062 (2020).","journal-title":"J. Hepatol."},{"key":"101_CR6","doi-asserted-by":"crossref","unstructured":"Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). (2000).","DOI":"10.1136\/gut.46.3.420"},{"issue":"2","key":"101_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jhep.2016.10.007","volume":"66","author":"C B\u00e9guelin","year":"2017","unstructured":"B\u00e9guelin, C. et al. Hepatitis delta-associated mortality in HIV\/HBV-coinfected patients. J. Hepatol. 66(2), 297\u2013303 (2017).","journal-title":"J. Hepatol."},{"issue":"5","key":"101_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/liv.13604","volume":"38","author":"A Wranke","year":"2018","unstructured":"Wranke, A. et al. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN). Liver Int. 38(5), 842\u2013850 (2018).","journal-title":"Liver Int."},{"issue":"2","key":"101_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/hep.31055","volume":"72","author":"MI Elsaid","year":"2020","unstructured":"Elsaid, M. I. et al. Economic and Health Care Burdens of Hepatitis Delta: A Study of Commercially Insured Adults in the United States. Hepatology 72(2), 399\u2013411 (2020).","journal-title":"Hepatology"},{"key":"101_CR10","doi-asserted-by":"publisher","first-page":"105650","DOI":"10.1016\/j.jcv.2024.105650","volume":"171","author":"A Parfut","year":"2024","unstructured":"Parfut, A. et al. Impact of anti-HDV reflex testing at HBs antigen positive discovery in a single center France: Support for primary HDV screening in France. J. Clin. Virol. 171, 105650 (2024).","journal-title":"J. Clin. Virol."},{"key":"101_CR11","doi-asserted-by":"crossref","unstructured":"Buti M, Gonzalez A, Riveiro\u2010Barciela M, Bourliere M. Management of chronic HBV\u2010HDV patients chronic HBV\u2010HDV infection: A review on new management options. UEG J., (2023).","DOI":"10.1002\/ueg2.12494"},{"key":"101_CR12","unstructured":"Organizaci\u00f3n Mundial de la Salud (OMS). Estrategia Mundial del Sector de la Salud contra las Hepatitis V\u00edricas 2016\u20132021: Hacia el fin de las hepatitis v\u00edricas. Ginebra: OMS. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/250578\/WHO-HIV-2016.06 spa.pdf?sequence=1&isAllowed=y, (2016)."},{"key":"101_CR13","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol. (2017)."},{"issue":"9","key":"101_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.gastrohep.2020.03.011","volume":"43","author":"M Rodr\u00edguez","year":"2020","unstructured":"Rodr\u00edguez, M. et al. Documento de consenso de la Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado sobre el tratamiento de la infecci\u00f3n por el virus de la hepatitis B (2020). Gastroenterol Hepatol. 43(9), 559\u2013587. https:\/\/doi.org\/10.1016\/j.gastrohep.2020.03.011 (2020).","journal-title":"Gastroenterol Hepatol."},{"issue":"1","key":"101_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin, S. K. et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 10(1), 1\u201398. https:\/\/doi.org\/10.1007\/s12072-015-9675-4 (2016).","journal-title":"Hepatol Int."},{"issue":"4","key":"101_CR16","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault, N. A. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67(4), 1560\u20131599 (2018).","journal-title":"Hepatology"},{"key":"101_CR17","unstructured":"Casado Mart\u00edn M, Camelo Castillo A, Barrera Baena P, Bel\u00e9n P\u00e9rez A, Pinazo Bandera JM, Garc\u00eda Barrionuevo A, et al. Co-02. Estado actual de la hepatitis delta en andaluc\u00eda. Implantacion del diagnostico en un solo paso. Revista andaluza de patolog\u00eda digestiva. (2023)."},{"key":"101_CR18","unstructured":"G\u00f3mez Gonz\u00e1lez I. Prevalencia de la hepatitis D en la Comunidad Valenciana: b\u00fasqueda activa de casos (0890). Santiago de Compostela: XXVI Congreso Nacional de la Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC), (2023)."},{"issue":"2","key":"101_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.gastrohep.2022.09.009","volume":"46","author":"J Crespo","year":"2023","unstructured":"Crespo, J. et al. Recomendaciones para el diagn\u00f3stico integral de las hepatitis virales cr\u00f3nicas en una \u00fanica extracci\u00f3n anal\u00edtica. Gastroenterol. Hepatol. 46(2), 150\u2013162 (2023).","journal-title":"Gastroenterol. Hepatol."},{"issue":"10","key":"101_CR20","doi-asserted-by":"publisher","first-page":"100547","DOI":"10.1016\/j.jhepr.2022.100547","volume":"4","author":"A Palom","year":"2022","unstructured":"Palom, A. et al. Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D. JHEP Rep. 4(10), 100547 (2022).","journal-title":"JHEP Rep."},{"key":"101_CR21","doi-asserted-by":"publisher","first-page":"114039","DOI":"10.1016\/j.jviromet.2020.114039","volume":"289","author":"J Mart\u00ednez-Campreci\u00f3s","year":"2021","unstructured":"Mart\u00ednez-Campreci\u00f3s, J. et al. Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitis. J. Virol. Methods 289, 114039 (2021).","journal-title":"J. Virol. Methods"},{"issue":"12","key":"101_CR22","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1111\/liv.15776","volume":"43","author":"M Buti","year":"2023","unstructured":"Buti, M., Dom\u00ednguez-Hern\u00e1ndez, R., Palom, A., Esteban, R. & Casado, M. \u00c1. Impact of hepatitis D reflex testing on the future disease burden: A modelling analysis. Liver Int. 43(12), 2611\u20132614 (2023).","journal-title":"Liver Int."},{"issue":"2","key":"101_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jhep.2023.10.043","volume":"80","author":"Polaris Observatory Collaborators","year":"2024","unstructured":"Polaris Observatory Collaborators. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories. J Hepatol. 80(2), 232\u2013242. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.043 (2024).","journal-title":"J Hepatol."},{"issue":"2","key":"101_CR24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jhep.2023.02.041","volume":"79","author":"HA Razavi","year":"2023","unstructured":"Razavi, H. A. et al. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV\/HDV-prevalence countries. J. Hepatol. 79(2), 576\u2013580. https:\/\/doi.org\/10.1016\/j.jhep.2023.02.041 (2023).","journal-title":"J. Hepatol."},{"key":"101_CR25","doi-asserted-by":"crossref","unstructured":"Casas MDLP, Garc\u00eda F, Freyre-Carrillo C, Montiel N, De La Iglesia A, Viciana I, et al. Towards the elimination of hepatitis C: implementation of reflex testing in Andalusia. Rev. Esp Enferm Dig. (2020).","DOI":"10.17235\/reed.2020.6370\/2019"},{"key":"101_CR26","doi-asserted-by":"publisher","unstructured":"Garc\u00eda F, Dom\u00ednguez-Hern\u00e1ndez R, Casado M, Mac\u00edas J, T\u00e9llez F, Pascasio JM, Casado M\u00c1, Alados JC. The simplification of the diagnosis process of chronic hepatitis C is cost-effective strategy. Enferm Infecc Microbiol Clin (Engl Ed). https:\/\/doi.org\/10.1016\/j.eimc.2019.03.001. (2019).","DOI":"10.1016\/j.eimc.2019.03.001"},{"key":"101_CR27","doi-asserted-by":"publisher","unstructured":"Buti M, Calleja JL, Rodr\u00edguez M\u00c1, Dom\u00ednguez-Hern\u00e1ndez R, Cantero H, Espinoza N, Casado M\u00c1. Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D. Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.gastrohep.2024.502241. (2024).","DOI":"10.1016\/j.gastrohep.2024.502241"},{"issue":"7","key":"101_CR28","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3390\/v15071506","volume":"15","author":"A Palom","year":"2023","unstructured":"Palom, A. et al. Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain. Viruses 15(7), 1506 (2023).","journal-title":"Viruses"},{"key":"101_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000584","author":"H Wedemeyer","year":"2023","unstructured":"Wedemeyer, H. et al. HDV RNA Assays Writing Group at the HBV Forum HDV RNA assays: Performance characteristics, clinical utility, and challenges. Hepatology https:\/\/doi.org\/10.1097\/HEP.0000000000000584 (2023).","journal-title":"Hepatology"},{"issue":"4","key":"101_CR30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.cld.2023.05.008","volume":"27","author":"E Umukoro","year":"2023","unstructured":"Umukoro, E., Alukal, J. J., Pak, K. & Gutierrez, J. State of the Art: Test all for Anti-Hepatitis D Virus and Reflex to Hepatitis D Virus RNA Polymerase Chain Reaction Quantification. Clin Liver Dis. 27(4), 937\u2013954. https:\/\/doi.org\/10.1016\/j.cld.2023.05.008 (2023).","journal-title":"Clin Liver Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00101-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00101-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00101-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T09:01:33Z","timestamp":1746176493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00101-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["101"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00101-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RDH is an employee of Pharmacoeconomics & Outcomes Research Iberia (PORIB), a consulting firm specializing in economic evaluation and health outcomes research that has been paid to provide methodological support for the project and for writing the manuscript. FGG has received funding for research contracts, advisory boards, and conference attendance from Abbvie, Gilead, Hologic, Roche, MSD, Qiagen, and Pfizer. MCM has received funding for research contracts, advisory boards, and conference attendance from Abbvie, Gilead, Roche, MSD, and Advanz Pharma. JMRZ has received funding for research contracts, advisory boards, and conference attendance from Abbvie, Gilead, Roche, and MSD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We confirm that this study has been approved by the Ethics Committee of Hospital Costa del Sol. All methods were carried out in accordance with relevant guidelines and regulations. Due to the nature of the study, the Clinical Research Ethics Committee granted an exemption from the requirement to obtain informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"15413"}}